DURATION OF POSTVACCINAL IMMUNITY AGAINST HEPATITIS B IN HEALTH CARE WORKERS IN ST. PETERSBURG

Código QR

DURATION OF POSTVACCINAL IMMUNITY AGAINST HEPATITIS B IN HEALTH CARE WORKERS IN ST. PETERSBURG

Immunization against hepatitis В is the most effective method of preventing this disease. Study of quantitative characteristics of postvaccinal immunity against viral hepatitis В in 214 health care workers from different institutions of St. Petersburg has shown that HBV vaccine provides a long term...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Z. P. Kalinina, M. G. Dar’ina, K. N. Movchan, O. Yu. Mamicheva, I. B. Gagarkina, T. Ya. Averina, O. A. Balabash, L. I. Yefimova, I. V. Potemkina
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2015
Materias:	hepatitis b virus (hbv) immunization prevention health-care workers anti-hbsag Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/b29aa2ec75bb4c288a269d007e1c5a9e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prediction for HBsAg seroconversion in children with chronic hepatitis B
por: Yan-Wei Zhong, et al.
Publicado: (2021)

Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers
por: Mary C. Kuhns, et al.
Publicado: (2021)

GENETIC VARIANTS OF HEPATITIS B VIRUS IN PRIMARY DONORS IN ASTANA, KAZAKHSTAN
por: Yu. V. Ostankova, et al.
Publicado: (2017)

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing
por: Ying Wang, et al.
Publicado: (2021)

Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis
por: Aixin Song, et al.
Publicado: (2021)

A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients
por: Chiao-Fang Teng, et al.
Publicado: (2018)

Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees
por: Ronald E. Engle, et al.
Publicado: (2020)

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN
por: Yu. V. Ostankova, et al.
Publicado: (2018)

Seroprevalence and associated factors of hepatitis B virus infection among HIV-positive adults attending an antiretroviral treatment clinic at Wolaita Sodo University Referral Hospital
por: Goa A, et al.
Publicado: (2019)

IMMUNOLOGICAL FEATURES IN LIVER CIRRHOSIS INDUCED BY HEPATITIS B VIRUS
por: O. I. Urazova, et al.
Publicado: (2014)

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Percy A. Knolle, et al.
Publicado: (2021)

E2 Site Mutations in S Protein Strongly Affect Hepatitis B Surface Antigen Detection in the Occult Hepatitis B Virus
por: Hao Wang, et al.
Publicado: (2021)

Hepatitis Fulminante en Hijo de Madre Portadora Crónica de Anfígeno de Hepatitis B de Superficie
por: Zacarías S.,José
Publicado: (1985)

Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation
por: Juhan Lee, et al.
Publicado: (2018)

Analysis of the Physicochemical Properties, Replication and Pathophysiology of a Massively Glycosylated Hepatitis B Virus HBsAg Escape Mutant
por: Md. Golzar Hossain, et al.
Publicado: (2021)

Assessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
por: Izabela Szczygielska, et al.
Publicado: (2020)

Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial
por: Sheikh Mohammad Fazle Akbar, et al.
Publicado: (2021)

Silicon Nanowire Field-Effect Transistor as Label-Free Detection of Hepatitis B Virus Proteins with Opposite Net Charges
por: Suh Kuan Yong, et al.
Publicado: (2021)

Gating strategy for plasmablast enumeration after hepatitis B vaccination
por: M. G. Byazrova, et al.
Publicado: (2021)

Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study
por: Min Jiang, et al.
Publicado: (2021)

A nuanced role of the small loop of hepatitis B virus small envelope protein in virion morphogenesis and secretion
por: Chih-Hsu Chang, et al.
Publicado: (2021)

Prevalence of anti HDV in HBV carriers in Babol during 2000-02
por: MR Hassanjani Roshan, et al.
Publicado: (2004)

Canonical and Divergent N-Terminal HBx Isoform Proteins Unveiled: Characteristics and Roles during HBV Replication
por: Sergio Hernández, et al.
Publicado: (2021)

Prognostic Value of Serum Exosomal AHCY Expression in Hepatitis B-Induced Liver Cirrhosis
por: Ling Tong, et al.
Publicado: (2021)

Women Workers of St. Petersburg in the Late 19th — early 20th Centuries
por: I. A. Tropov, et al.
Publicado: (2020)

Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Lorenzo Onorato, et al.
Publicado: (2021)

In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors
por: Shonisani Wendy Limani, et al.
Publicado: (2021)

The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection
por: Hiroyuki Amano, et al.
Publicado: (2021)

Epidemiology and Challenges of HBV/HIV Co-Infection Amongst HIV-Infected Patients in Endemic Areas: Review
por: Weldemhret L
Publicado: (2021)

THE DYNAMICS OF TITERS CHANGES OF SPECIFIC IMMUNOGLOBULINS TO HBsAg IN SERUM AND YOLK OF QUAIL EGGS IN CASE OF USING OF DIFFERENT PREPARATION FOR IMMUNIZATION
por: V. B. Sboychakov, et al.
Publicado: (2014)

EPIDEMIOLOGY OF ADENOVIRAL INFECTION IN ST. PETERSBURG
por: I. V. Ovsyannikova, et al.
Publicado: (2018)

Health-related quality of life for adults living with hepatitis B in the United States: a qualitative assessment
por: Catherine Freeland, et al.
Publicado: (2021)

Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management
por: Cannizzaro MV, et al.
Publicado: (2017)

Inmunogenicidad de una vacuna recombinante anti hepatitis B en personal de salud
por: GARCÍA C.,PATRICIA, et al.
Publicado: (2002)

EPIDEMIC RISE IN THE INCIDENCE OF INFLUENZA IN ST. PETERSBURG IN 2016
por: N. S. Bashketova, et al.
Publicado: (2017)

Assessment of Knowledge, Attitude, and Practice of Health-Care Workers Towards Hepatitis B Virus Prevention in Kabul, Afghanistan
por: Roien R, et al.
Publicado: (2021)

Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus
por: Ali A. Dawood, et al.
Publicado: (2021)

Prognostic impact of hepatitis B virus infection in patients with primary cervical cancer
por: Xiaoyan Feng, et al.
Publicado: (2021)

Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
por: Li,Wenting, et al.
Publicado: (2019)

Construction of bicistronic cassette for co-expressing hepatitis B surface antigen and mouse granulocyte-macrophage colony stimulating factor as adjuvant in tobacco plant
por: Sara Mohammadzadeh, et al.
Publicado: (2019)